Compare BLCO & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | FNB |
|---|---|---|
| Founded | 1853 | 1864 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.3B |
| IPO Year | 2022 | N/A |
| Metric | BLCO | FNB |
|---|---|---|
| Price | $17.44 | $17.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | $17.31 | ★ $18.64 |
| AVG Volume (30 Days) | 342.5K | ★ 4.5M |
| Earning Date | 02-18-2026 | 01-20-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | N/A | ★ 28.48 |
| EPS | N/A | ★ 1.40 |
| Revenue | ★ $4,976,000,000.00 | $1,587,400,000.00 |
| Revenue This Year | $8.06 | $17.82 |
| Revenue Next Year | $5.79 | $8.12 |
| P/E Ratio | ★ N/A | $12.48 |
| Revenue Growth | 6.23 | ★ 6.34 |
| 52 Week Low | $10.45 | $10.88 |
| 52 Week High | $18.14 | $17.93 |
| Indicator | BLCO | FNB |
|---|---|---|
| Relative Strength Index (RSI) | 58.26 | 54.60 |
| Support Level | $17.18 | $16.86 |
| Resistance Level | $17.86 | $17.59 |
| Average True Range (ATR) | 0.42 | 0.33 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 70.12 | 56.25 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.